App-Quantinova.ai

Sirolimus Stents, Late Incomplete Stent Malapposition, in Stent Restenosis, Oh My- Glagovs Phenomenon Revisited

Rony Shimony - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Clinical Events Avoided With Apixaban Compared to Current Standard of Care for the Initial and Extended Treatment and Prevention of Venous Thromboembolism

Melissa Hamilton - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

apixaban

Platelet Reactivity Measurements Before and After Percutaneous Coronary Intervention Among Patients Undergoing Early Invasive Management for Acute Coronary Syndrome

Chin Chee Tang - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Adolescents: An Open-label Phase IIa Study

Thorsten Lehr - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Pradax

Normal Angiographic Appearance of the Coronary Arteries is Common in Antiphosopholipid Syndrome Patients Presenting With Acute Coronary Syndrome

Neeraja Yedlapati - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Nitroglycerin

Is It Safe Placing a Drug Eluting Stent in Patients Requiring Long-term Anticoagulation?

Alba Santos - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Efficacy of Dabigatran versus Warfarin in Patients With Acute Venous Thromboembolism and Thrombophilia: A Pooled Analysis of RE-COVER and RE-COVER II

Sam Schulman - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Pradax

Transcutaneous Aortic Valve Replacement -Is Anticoagulation Protective?

Kaylan Mucci - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Pradax

What are Key Factors to Achieve Better Stent Apposition at Left Main Bifurcation by Culottes Stenting Technique? Micro-CT Analysis Using Bifurcated Elastic Coronary Artery Models

Takafumi Ohba - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Thrombin-Inhibiting Nanoparticles Prevent Growth of Fibrin Clots by Inhibiting and Adhering to Clot-Bound Thrombin

Rohun U Palekar - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

Major Adverse Cardiac Events After Non-cardiac Surgery Following Previous Percutaneous Coronary Intervention With Stent Implantation

Summer Syed - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Clopidogrel bisulfate

Sex Differences in Mortality in Women and Men with Obstructive Coronary Artery Disease and Acute Coronary Syndrome

Sasko Kedev - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Drug Delivery Strategies Employing Angioplasty Balloons for Treatment of Atherosclerosis

Roshni Iyer - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Protection of CD39 Transgenic Mice From Cerebral Ischemic Injury

Danica Petrovic-Djergovic - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The ORBIT-AF Bleeding Score: a Simple Score to Assess Major Bleeding Risk in Atrial Fibrillation

DaJuanicia N. Simon - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Is there a Correlation Between Bleeding Risk Score and Platelet Aggregability?

Remo Holanda de Mendonca Furtado - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Prognostically Important Myocardial Infarctions are Markedly Underreported in Patients Undergoing Percutaneous Coronary Intervention: Insights from CHAMPION PHOENIX

Deepak L Bhatt - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Readmissions After Implantation of Continuous-Flow Left Ventricular Assist Devices: A Comparison Between the HeartMate II and the HeartWare Devices

Mary E Davis - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

TEVAR Remodels the Thoracic and Abdominal Aorta in Acute DeBakey 3 Dissection: Early Results

Chun Li - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Platelet mTOR is an Important Mediator of Arterial Thrombosis

Maya Hwewon Kim - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Rapacan

Filters

7277 Abstracts